P22 THE PROGNOSTIC ROLE OF 1Q ABNORMALITIES IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS

por Attucci, I., Pilerci, S., Bonifacio, S., Pengue, L., Buzzichelli, A., Messeri, M., Vannucchi, AM, Antonioli, E.
Publicado 2023

P17 CLONAL PLASMA-CELLS IN STEM CELL APHERESIS AS A PREDICTOR OF PROGRESSION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS ELEGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION

por Pilerci, S., Attucci, I., Pengue, L., Peruzzi, B., Caporale, R., Bencini, S., Messeri, M., Buzzichelli, A., Boncompagni, R., Nozzoli, C., Vannucchi, A.M., Antonioli, E.
Publicado 2023

P48 CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED REFRACTORY MULTIPLE MYELOMA: A PROSPECTIVE REAL-LIFE EXPERIENCE OF THE REGIONAL TUSCAN MYELOMA NETWORK (RTM)

por Attucci, I., Antonioli, E., Pilerci, S., Buda, G., Gozzetti, A., Candi, V., Simonetti, F., Del Giudice, ML., Ciofini, S., Staderini, M., Grammatico, S., Buzzichelli, A., Messeri, M., Bocchia, M., Galimberti, S., Vannucchi, AM
Publicado 2023